Allplex™ SARS-CoV-2 Master Assay by Seegene Inc

Manufacturer Seegene Inc  |  Available Worldwide
5.0
/
5.0
  |  1 reviews
Full Screening for SARS-CoV-2 and variants including five notable mutations in S gene


Allplex™ SARS-CoV-2 Master Assay by Seegene Inc product image
Allplex™ SARS-CoV-2 Master Assay

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.




Average Rating: 5.0
1 Scientist has reviewed this product

5 out of 5
Ease of use
5 out of 5
After sales service
5 out of 5
Value for money


  • Status:

    Advanced Reviewer
  • Member since: 2020

  • Organization: Seoul National University



  • Ease of use
    5 out of 5
    After sales service
    5 out of 5
    Value for money
    5 out of 5
Share this Review on LinkedinShare this Review on TwitterShare this Review on Facebook
Worth it.
Rating: 5.0

  • Application Area: Molecular diagnostics, SARS-CoV-2 detection

"Using 5 fluorescence channels, you can screen four wild type genes and five S variant genes in one assay. It includes positive control and internal control for validation."

Review date: 15 May 2021 | Allplex™ SARS-CoV-2 Master Assay

Full Screening for SARS-CoV-2 and variants including five notable mutations in S gene

FEATURES

  • Multiplex real-time PCR

Accurate multiplex test for screening of 4 target genes of SARS-CoV-2 and its variants in a single tube

  • Short TAT

Results within 2 hours after extraction

  • Variant surveillance

Monitoring the most reported SARS-CoV-2 variants of concern for efficient infection control

  • User-friendly workflow

Convenient workflow using Seegene’s automated one platform

  • Automatic data analyzer

Automated data interpretation and LIS interlocking with Seegene Viewer

  • Whole process validation

Whole process validation from extraction to PCR by whole process control

  • Powerful performance

PCR with high sensitivity and specificity